UMZOON
LIVE

Serial Number

79186802

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 8, 2016

Add to watchlist:

No watchlists yet
View on USPTO

UMZOON Trademark

Serial Number: 79186802 • Registration: 5052071

UMZOON is a trademark filed by NOVARTIS AG on February 8, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 8, 2016

Registration Date

October 4, 2016

Published for Opposition

July 19, 2016

Cancellation Date

January 9, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; stem cells for pharmaceutical and medical use

Collection and preservation of human biological tissue, blood and cells for medical use; medical diagnostic testing services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 3, 2021 FINO
REFUSAL PROCESSED BY IB
Apr 10, 2020 RFNT
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 24, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 24, 2020 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 3, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 9, 2017 FICS
FINAL DISPOSITION PROCESSED
Feb 9, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 4, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 4, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jul 19, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2016 NONP
REFUSAL PROCESSED BY IB
Jun 10, 2016 RFNP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 2, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 2, 2016 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 26, 2016 RFCS
REFUSAL PROCESSED BY MPU
May 26, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 26, 2016 RFCR
NON-FINAL ACTION WRITTEN
May 25, 2016 CNRT
ASSIGNED TO EXAMINER
May 24, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
May 24, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 19, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 19, 2016 REPR